Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with Age

Total Page:16

File Type:pdf, Size:1020Kb

Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with Age Cell Reports, Volume 25 Supplemental Information Heterogeneous Responses of Hematopoietic Stem Cells to Inflammatory Stimuli Are Altered with Age Mati Mann, Arnav Mehta, Carl G. de Boer, Monika S. Kowalczyk, Kevin Lee, Pearce Haldeman, Noga Rogel, Abigail R. Knecht, Daneyal Farouq, Aviv Regev, and David Baltimore A B 80 Young 60 Young Aged Aged *** *** 60 40 * * 40 *** *** * *** *** * 20 20 0 0 Myeloid cells (% of CD45+ cells) Granulocytes (% of CD45+ cells) C Young D Young 40 Aged 80 Aged *** 30 *** 60 *** *** *** *** *** 20 40 10 20 T cells (% of CD45+ cells) B cells (% of CD45+ cells) 0 0 0 hr 72 hr 3 wk 6 wk 9 wk 0 hr 72 hr 3 wk 6 wk 9 wk E Spleen F Bone marrow 30 ** 1.5 * 0.3 * ) ) CD45 f ) 1.0 0.2 20 Lin- o f Lin- o (% f s (% o ell (% Cs c 0.5 S 0.1 10 -H SKs eloid L LT My 0 0.0 0.0 35 *** 0.20 * 0.8 NS ) ) 0.15 ) 0.6 Lin- 30 Lin- f f CD45 o o f o (% 0.10 (% 0.4 s (% s SC PPs ell M 25 -H T c ST 0.05 0.2 20 0 0 Young Aged Young Aged Young Aged Figure S1. Aged mice challenged with LPS demonstrate increased myeloid output and an increased frequency of bone marrow HSPCs. Related to Figure 1. (A)-(C) Young (8-12 weeks) and aged (20-24 months) mice were exposed to single sub-lethal dose of LPS and peripheral blood (A) myeloid cell and (B) granulocyte (C) T cell, (D) B cell, frequencies were measured by flow cytometry at the indicated time points after LPS exposure (n = 4-14 per group). (E)-(F) Mice were harvested 2-3 weeks after the second LPS injection. (E) Splenic CD11b+ cell and CD3e+ cell frequencies are shown. (n=4 per group) (F) The frequencies of different bone marrow progenitor cells are shown. LT-HSCs were gated using the markers Lineage-cKit+Sca1+CD150+CD48-, ST-HSCs using the markers Lineage-cKit+Sca1+CD150-CD48-, MPPs using the markers Lineage-cKit+Sca1+CD150-CD48+ and LSKs using the markers Lineage-cKit+Sca1+ (n=5-7 per group). Data represent at least two independent experiments and are presented as mean ± SEM. * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001 using 2way ANOVA (A-D), or T test (E,F). A B Young mice primary transplant Aged mice primary transplant 80 80 LT-HSC, no stim 60 60 LT-HSC, stim ST-HSC, no stim merism 40 merism 40 ST-HSC, stim hi hi MPP, no stim % c % 20 c % 20 MPP, stim 0 0 4wk 8wk 12wk 4wk 8wk 12wk Time post-reconstitution Time post-reconstitution C D Young mice secondary transplant Aged mice secondary transplant 50 60 LT-HSC, no stim LT-HSC, stim 40 ST-HSC, no stim 40 30 ST-HSC, stim merism merism MPP, no stim hi hi 20 MPP, stim 20 % c % % c % 10 0 0 4wk 8wk 4wk 8wk Time post-reconstitution Time post-reconstitution E F ns ns 0.6 100 80 0.4 60 40 0.2 LT-HSCs (% of Lin-) 20 CD41+ LT-HSCs (% of Lin-) 0.0 0 ns ns G 3000 H 2500 2000 2000 1500 + LT-HSCs + 41 1000 CD Total LT-HSCs Total 1000 500 Total Total 0 0 No stim Stim No stim Stim No stim Stim No stim Stim Young mice Aged mice Young mice Aged mice Figure S2. Transplantation of LT-HSCs, ST-HSCs and MPPs from young and aged mice, both with and without stimulation, demonstrates only LT-HSCs have long term reconstitution potential. Related to Figure 1. CD45.2 HSPCs were sorted as described in Figure 2 and treated with or without LPS/Pam3csk4 in vitro prior to transplantation into lethally irradiated CD45.1 recipient mice along with CD45.1 bone marrow helper cells. (A)-(D) These panels demonstrate that LT-HSCs from both (A) young and (B) aged mice, had the ability to maintain long term reconstitution even when stimulated in vitro prior to transplantation. All MPPs failed to maintain long term hematopoietic output. (C)-(D) Secondary transplantation was performed using bone marrow cells obtained from mice in parts (A) and (B). Only LT-HSCs were able to maintain long term reconstitution during secondary transplantation. This was the case for both (D) young and (E) aged LT-HSCs, and both initially unstimulated and stimulated LT-HSCs. (E)-(H) The bone marrow compartment for all mice was analyzed 3 months post-reconstitution for the (E) frequency and (G) total number of LT-HSCs, as well as the (F) frequency and (H) total number of CD41+ LT-HSC subsets. Data represent at least two independent experiments (n=7-12 per group) and are presented as mean ± SEM and analyzed using 1way ANOVA (E-H). Young LT-HSCs A Young LT-HSCs Aged LT-HSCs C Young LT-HSCs 15 15B 15 Aged LT-HSCs BMDCs Aged LT-HSCs BMDCs BMDCs 10 10 10 5 5 5 log2(TPM) IL6 for log2(TPM) for IL1b log2(TPM) for TNFa 0 0 0 0 5 10 15 0 5 10 15 0 5 10 15 Time (hours) Time (hours) Time (hours) 40 D E 40 H 20 Tm4sf1 ***** * 20 Myo1e * nostim nostim Gpr183 Zfp773 *** * Wwtr1 Rnd3 0 Mid1 0 Jun *** Plscr2 ** Ptprk ** Matn4 ** −20 Dnm3 **** −20 Ptafr **** Bmp4 * *** Ltbp4 **** Gpr64 −40 log(FC) aged ST-HSCs Gstm2 * aged MPPs Plcl1 * ** 40 40 Gprc5c 5 tSNE2 Thsd4 tSNE2 *** young MPPs young ST-HSCs Cadm1 0 Bmpr1a **** Epas1 * −5 20 Csrnp2 20 Rorb **** Gm9199 stim * stim Ramp2 ***** Gpx3 *** 0 Sbspon ***** * 0 Osmr ***** **** Muc1 Selp ***** ** Dhrs3 −20 Clca1 * −20 Clec1a * ** Vwf ***** Jam2 ** Ehd3 ***** −40 Vmp1 ** Itgb3 Nupr1 *** ** −25 0 25 −40 −20 0 20 Gda Wdfy1 ** tSNE1 tSNE1 Dynlt1b * Serpina3g ** Serinc3 * F Regulation of NF-kB import into nucleus G Plac8 ***** *** Platelet-derived growth factor receptor signaling pathway cluster 2 aged Negative regulation of lymphocyte differentiation Positive regulation of acute inflammatory response vs vs Sterol biosynthetic process Negative regulation of lipid catabolic process cluster 3 young Keratinocyte differentiation G-protein coupled receptor signaling pathway stim LT no-stim LT Negative regulation of T-helper type 1 immune response Positive regulation of B cell differentiation Oncostatin-M-mediated signaling pathway Regulation of lymphocyte activation Regulation of signaling Positive regulation of hematopoiesis Extracellular matrix Regulation of endothelial cell development Negative regulation of cell adhesion Cell proliferation Macrophage proliferation Cell-cell adhesion Regulation of migration Positive regulation of cytokine biosynthtic pathway Regulation of localization Immune response 02461 3 5 02468 -log(p-value) -log(p-value) J I Slamf1 Vwf K Itga2b (CD150) 0.2 (CD41) 25 0.2 0.4 0.2 0.4 0.6 0.4 0.6 0.8 0.6 0.8 1.0 0.8 0 1.0 1.2 1.0 1.2 1.4 1.2 tSNE−2 1.4 1.6 1.4 1.6 1.6 −25 1.8 1.8 2.0 −25 0 25 −25 0 25 −25 0 25 tSNE−1 tSNE−1 tSNE−1 L M Z score 4 2 0 mLT-HSC gene signature 400 200 0 Score Aged Young Individual cells ranked Individual cells ranked Figure S3. Inflammatory challenge HSPCs in vitro leads to induction of inflammatory cytokines and reveals a myeloid biased gene signature in LT-HSCs. Related to Figures 2, 3. (A)-(E) LT-HSCs from young and aged mice were exposed to LPS and Pam3CSK4 in vitro for the indicated time and subjected to bulk RNA-sequencing. Shown are the log2(TPM) values for (A) IL6, (B) IL1β and (C) TNFα over time along with values for BMDCs obtained from (Jovanovic et al., 2015). (D)-(L) LT-HSCs, ST-HSCs and MPPs from young and aged mice were stimulated with LPS and Pam3CSK4 and sorted for single-cell RNA-sequencing. (D)-(E) Single- cell t-SNE plots (as in Figure 3) showing (D) MPPs and (E) ST-HSCs among unstimulated and stimulated cells, and color coded by mouse age. Gene Ontology analysis for all genes differentially upregulated (F) or downregulated (G) in LT-HSCs in cluster 3 vs cluster 2. (H) A gene signature defined in unstimulated LT-HSCs based on differentially expressed genes in stimulated LT-HSCs. Comparably changed genes between unstimulated aged vs young were isolated and used to define this preliminary signature, which was later used to initialize a k-means clustering approach. (I)-(K) t-SNE plots of all LT-HSCs analyzed by single-cell RNA-seq showing the mRNA expression levels, color coded for log2(TPM), of (I) CD150, (J) Vwf and (K) CD41 in each individual cell. (L) A gene signature learned from stimulated LT-HSCs shows the underlying heterogeneity among stimulated LT-HSCs. Heat-map demonstrates the expression of all genes in the inferred gene signature for each single stimulated LT-HSC. The panels below shows a score for each cell based on the expression of genes in this gene signature. The color-coded bar at the bottom shows the age of the mouse of origin. (M) The same signature in Figure 3G was applied to an independent data set of unstimulated young and aged LT-HSCs (Kowalczyk et al., 2015). Data represent at least two independent experiments (n=9) and are presented as mean ± SEM. ** ** ** ** ** B 80 A ** ns 100 60 80 n 40 dow 60 ck no 20 A k A 40 B cells (% of GFP+) RN % m % 0 4 5 4 5 3 3 4 4 20 1 1 MG Klf Klf MG Klf Klf Ikzf Ikzf Stat Stat Zbtb Zbtb HoxA9 HoxA9 0 Young mice Aged mice 1 4 5 4 3 MG Klf Klf Ikzf Stat Zbtb HoxA9 C 40 D 25 ** E 20 ** ** ** * ** ** ** * 20 30 15 15 20 10 10 10 5 T cells (% of GFP+) 5 Myeloid cells (% of GFP+) Granulocytes (% of GFP+) 0 0 0 1 1 1 1 1 1 4 4 4 4 4 4 4 4 4 4 4 4 3 3 3 3 3 3 5 5 5 5 5 5 MG MG MG MG MG MG Klf Klf Klf Klf Klf Klf Klf Klf Klf Klf Klf Klf Ikzf Ikzf Ikzf Ikzf Ikzf Ikzf Stat Stat Stat Stat Stat Stat Zbtb Zbtb Zbtb Zbtb Zbtb Zbtb HoxA9 HoxA9 HoxA9 HoxA9 HoxA9 HoxA9 Young mice Aged mice Young mice Aged mice Young mice Aged mice Young, MG Young, MG Young, MG 80 80 80 F Aged, MG Aged, MG Aged, MG Young, shKLF5 Young, shIKZF1 Young, shSTAT3 70 Aged, shKLF5 70 ^ Aged, shIKZF1 70 ^ ^ Aged, shSTAT3 ^ ^ ^ 60 60 60 50 50 50 B cells (% of GFP+) 40 40 40 0 hr 72 hr 1 wk 3 wk 0 hr 72 hr 1 wk 3 wk 0 hr 72 hr 1 wk 3 wk G Young, MG Young, MG Young, MG 30 30 Aged, MG 30 Aged, MG Aged, MG ) Young, shKLF5 Young, shIKZF1 Young, shSTAT3 Aged, shKLF5 Aged,
Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • CD48 Is Critically Involved in Allergic Eosinophilic Airway Inflammation
    CD48 Is Critically Involved in Allergic Eosinophilic Airway Inflammation Ariel Munitz,1 Ido Bachelet,1 Fred D. Finkelman,2 Marc E. Rothenberg,3 and Francesca Levi-Schaffer1,4 1Department of Pharmacology, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; 2Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; 3Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio; and 4David R. Bloom Center for Pharmacology, Hebrew University of Jerusalem, Jerusalem, Israel Rationale: Despite ongoing research, the molecular mechanisms con- trolling asthma are still elusive. CD48 is a glycosylphosphatidylinositol- AT A GLANCE COMMENTARY anchored protein involved in lymphocyte adhesion, activation, and costimulation. Although CD48 is widely expressed on hematopoi- Scientific Knowledge on the Subject etic cells and commonly studied in the context of natural killer and CD48 is an activation molecule able to facilitate various cytotoxic T cell functions, its role in helper T cell type 2 settings cellular activities. Its role in asthma is unknown. has not been examined. Objectives: To evaluate the expression and function of CD48, CD2, and 2B4 in a murine model of allergic eosinophilic airway inflammation. What This Study Adds to the Field Methods: Allergic eosinophilic airway inflammation was induced by CD48 is upregulated in experimental asthma. Anti-CD48– ovalbumin (OVA)–alum sensitization and intranasal inoculation of based therapies may be useful for asthma and perhaps OVA or, alternatively, by repeated intranasal inoculation of Aspergil- various allergic diseases. lus fumigatus antigen in wild-type, STAT (signal transducer and acti- vator of transcription)-6–deficient, and IL-4/IL-13–deficient BALB/c mice.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Cytokine Regulation in Human CD4 T Cells by the Aryl Hydrocarbon
    www.nature.com/scientificreports OPEN Cytokine Regulation in Human CD4 T Cells by the Aryl Hydrocarbon Receptor and Gq-Coupled Received: 17 November 2017 Accepted: 9 July 2018 Receptors Published: xx xx xxxx Jeremy P. McAleer1, Jun Fan2, Bryanna Roar1, Donald A. Primerano2 & James Denvir2 Th17 cells contribute to host defense on mucosal surfaces but also provoke autoimmune diseases when directed against self-antigens. Identifying therapeutic targets that regulate Th17 cell diferentiation and/or cytokine production has considerable value. Here, we study the aryl hydrocarbon receptor (AhR)- dependent transcriptome in human CD4 T cells treated with Th17-inducing cytokines. We show that the AhR reciprocally regulates IL-17 and IL-22 production in human CD4 T cells. Global gene expression analysis revealed that AhR ligation decreased IL21 expression, correlating with delayed upregulation of RORC during culture with Th17-inducing cytokines. Several of the AhR-dependent genes have known roles in cellular assembly, organization, development, growth and proliferation. We further show that expression of GPR15, GPR55 and GPR68 positively correlates with IL-22 production in the presence of the AhR agonist FICZ. Activation of GPR68 with the lorazepam derivative ogerin resulted in suppression of IL-22 and IL-10 secretion by T cells, with no efect on IL-17. Under neutral Th0 conditions, ogerin and the Gq/11 receptor inhibitor YM254890 blunted IL-22 induction by FICZ. These data reveal the AhR- dependent transcriptome in human CD4 T cells and suggest the mechanism through which the AhR regulates T cell function may be partially dependent on Gq-coupled receptors including GPR68.
    [Show full text]
  • The Immunological Synapse and CD28-CD80 Interactions Shannon K
    © 2001 Nature Publishing Group http://immunol.nature.com ARTICLES The immunological synapse and CD28-CD80 interactions Shannon K. Bromley1,Andrea Iaboni2, Simon J. Davis2,Adrian Whitty3, Jonathan M. Green4, Andrey S. Shaw1,ArthurWeiss5 and Michael L. Dustin5,6 Published online: 19 November 2001, DOI: 10.1038/ni737 According to the two-signal model of T cell activation, costimulatory molecules augment T cell receptor (TCR) signaling, whereas adhesion molecules enhance TCR–MHC-peptide recognition.The structure and binding properties of CD28 imply that it may perform both functions, blurring the distinction between adhesion and costimulatory molecules. Our results show that CD28 on naïve T cells does not support adhesion and has little or no capacity for directly enhancing TCR–MHC- peptide interactions. Instead of being dependent on costimulatory signaling, we propose that a key function of the immunological synapse is to generate a cellular microenvironment that favors the interactions of potent secondary signaling molecules, such as CD28. The T cell receptor (TCR) interaction with complexes of peptide and as CD2 and CD48, which suggests that CD28 might have a dual role as major histocompatibility complex (pMHC) is central to the T cell an adhesion and a signaling molecule4. Coengagement of CD28 with response. However, efficient T cell activation also requires the partici- the TCR has a number of effects on T cell activation; these include pation of additional cell-surface receptors that engage nonpolymorphic increasing sensitivity to TCR stimulation and increasing the survival of ligands on antigen-presenting cells (APCs). Some of these molecules T cells after stimulation5. CD80-transfected APCs have been used to are involved in the “physical embrace” between T cells and APCs and assess the temporal relationship of TCR and CD28 signaling, as initiat- are characterized as adhesion molecules.
    [Show full text]
  • Proliferation by 2B4/CD48 Interactions T Cell
    Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions Taku Kambayashi, Erika Assarsson, Benedict J. Chambers and Hans-Gustaf Ljunggren This information is current as of September 29, 2021. J Immunol 2001; 167:6706-6710; ; doi: 10.4049/jimmunol.167.12.6706 http://www.jimmunol.org/content/167/12/6706 Downloaded from References This article cites 23 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/167/12/6706.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 29, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. ● Cutting Edge: Regulation of CD8؉ T Cell Proliferation by 2B4/CD48 Interactions1 Taku Kambayashi,2* Erika Assarsson,2* Benedict J. Chambers,* and Hans-Gustaf Ljunggren3*† To date, the only known 2B4-binding molecule is CD48. Bind- The biological function of 2B4, a CD48-binding molecule ex- ing studies have shown that CD48 has a 5–10 times stronger af- pressed on T cells with an activation/memory phenotype, is not finity for 2B4 than for CD2 (7, 8).
    [Show full text]
  • Understanding the Synergy of Nkp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy
    cells Article Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy 1,2, 3, 1, 1 Loris Zamai * , Genny Del Zotto y , Flavia Buccella y, Sara Gabrielli , Barbara Canonico 1 , Marco Artico 4, Claudio Ortolani 1 and Stefano Papa 1 1 Department of Biomolecular Sciences, University of Urbino “Carlo Bo”, 61032 Urbino, Italy; fl[email protected] (F.B.); [email protected] (S.G.); [email protected] (B.C.); [email protected] (C.O.); [email protected] (S.P.) 2 INFN-Gran Sasso National Laboratory, Assergi, 67100 L’Aquila, Italy 3 Area Aggregazione Servizi e Laboratori Diagnostici, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy; [email protected] 4 Department of Sensory Organs, Sapienza University of Rome, 00161 Rome, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0722-304319; Fax: +39-0722-304319 These authors contributed equally. y Received: 11 February 2020; Accepted: 13 March 2020; Published: 19 March 2020 Abstract: The NK cell population is characterized by distinct NK cell subsets that respond differently to the various activating stimuli. For this reason, the determination of the optimal cytotoxic activation of the different NK cell subsets can be a crucial aspect to be exploited to counter cancer cells in oncologic patients. To evaluate how the triggering of different combination of activating receptors can affect the cytotoxic responses of different NK cell subsets, we developed a microbead-based degranulation assay. By using this new assay, we were able to detect CD107a+ degranulating NK cells even within the less cytotoxic subsets (i.e., resting CD56bright and unlicensed CD56dim NK cells), thus demonstrating its high sensitivity.
    [Show full text]
  • Glucocorticoids Paradoxically Facilitate Steroid Resistance in T- Cell Acute Lymphoblastic Leukemias and Thymocytes
    Glucocorticoids paradoxically facilitate steroid resistance in T- cell acute lymphoblastic leukemias and thymocytes Lauren K. Meyer, … , David T. Teachey, Michelle L. Hermiston J Clin Invest. 2019. https://doi.org/10.1172/JCI130189. Research In-Press Preview Oncology Graphical abstract Find the latest version: https://jci.me/130189/pdf Meyer 1 1 Glucocorticoids paradoxically facilitate steroid resistance in T-cell acute lymphoblastic 2 leukemias and thymocytes 3 4 Authors: Lauren K. Meyer1, Benjamin J. Huang1, Cristina Delgado-Martin1, Ritu P. Roy2, Aaron 5 Hechmer2, Anica M. Wandler1, Tiffaney L. Vincent3, Paolo Fortina4, Adam B. Olshen2,5, Brent L. Wood6, 6 Terzah M. Horton7, Kevin M. Shannon1,2, David T. Teachey3*, and Michelle L. Hermiston1,2* 7 8 Affiliations: 9 1Department of Pediatrics, University of California, San Francisco, CA, USA 10 2Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA 11 3Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA 12 4Cancer Genomics and Bioinformatics Laboratory, Sidney Kimmel Cancer Center, Thomas Jefferson 13 University, Philadelphia, PA, USA 14 5Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA 15 6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA 16 7Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX, USA 17 *These authors contributed equally. 18 19 To whom correspondence should be addressed: 20 David Teachey: 3501 Civic Center Blvd., Philadelphia, PA, 19104. [email protected], 21 (267) 426-0762 22 Michelle Hermiston: 550 16th Street, 4th Floor Mailstop 0434, San Francisco, CA, 94143. 23 [email protected], (415) 476-2413 24 25 The authors have declared that no conflict of interest exists.
    [Show full text]
  • As an Invasive Receptor Cellular Prion Protein on Intestinal M Cells
    Cutting Edge: Brucella abortus Exploits a Cellular Prion Protein on Intestinal M Cells as an Invasive Receptor This information is current as Gaku Nakato, Koji Hase, Michio Suzuki, Masanobu Kimura, of September 29, 2021. Manabu Ato, Misaho Hanazato, Minoru Tobiume, Motohiro Horiuchi, Ryuichiro Atarashi, Noriyuki Nishida, Masahisa Watarai, Koichi Imaoka and Hiroshi Ohno J Immunol 2012; 189:1540-1544; Prepublished online 6 July 2012; Downloaded from doi: 10.4049/jimmunol.1103332 http://www.jimmunol.org/content/189/4/1540 References This article cites 30 articles, 8 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/189/4/1540.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 29, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Cutting Edge: Brucella abortus Exploits a Cellular Prion Protein on Intestinal M Cells as an Invasive Receptor ,† ,† ‡ ‡ x Gaku Nakato,* Koji Hase,* Michio{ Suzuki, Masanobu Kimura,‖ Manabu Ato, Misaho Hanazato,*,† Minoru Tobiume, Motohiro Horiuchi, Ryuichiro Atarashi,# Noriyuki Nishida,# Masahisa Watarai,** Koichi Imaoka,‡ and Hiroshi Ohno*,† Brucella abortus is a Gram-negative bacterium causing traffic, a process referred to as transcytosis (2, 3).
    [Show full text]
  • Mouse CD Marker Chart Bdbiosciences.Com/Cdmarkers
    BD Mouse CD Marker Chart bdbiosciences.com/cdmarkers 23-12400-01 CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD1d CD1.1, CD1.2, Ly-38 Lipid, Glycolipid Ag + + + + + + + + CD104 Integrin b4 Laminin, Plectin + DNAX accessory molecule 1 (DNAM-1), Platelet and T cell CD226 activation antigen 1 (PTA-1), T lineage-specific activation antigen 1 CD112, CD155, LFA-1 + + + + + – + – – CD2 LFA-2, Ly-37, Ly37 CD48, CD58, CD59, CD15 + + + + + CD105 Endoglin TGF-b + + antigen (TLiSA1) Mucin 1 (MUC1, MUC-1), DF3 antigen, H23 antigen, PUM, PEM, CD227 CD54, CD169, Selectins; Grb2, β-Catenin, GSK-3β CD3g CD3g, CD3 g chain, T3g TCR complex + CD106 VCAM-1 VLA-4 + + EMA, Tumor-associated mucin, Episialin + + + + + + Melanotransferrin (MT, MTF1), p97 Melanoma antigen CD3d CD3d, CD3 d chain, T3d TCR complex + CD107a LAMP-1 Collagen, Laminin, Fibronectin + + + CD228 Iron, Plasminogen, pro-UPA (p97, MAP97), Mfi2, gp95 + + CD3e CD3e, CD3 e chain, CD3, T3e TCR complex + + CD107b LAMP-2, LGP-96, LAMP-B + + Lymphocyte antigen 9 (Ly9),
    [Show full text]
  • (CD244)/CD48 Interaction: Lys68 and Glu70 in the V Domain of 2B4 Are Critical for CD48 Binding and Functional Activation of NK Cells1
    The Journal of Immunology Mutational Analysis of the Human 2B4 (CD244)/CD48 Interaction: Lys68 and Glu70 in the V Domain of 2B4 Are Critical for CD48 Binding and Functional Activation of NK Cells1 Stephen O. Mathew,2* Pappanaicken R. Kumaresan,2*† Jae Kyung Lee,* Van T. Huynh,* and Porunelloor A. Mathew3* Interaction between receptors and ligands plays a critical role in the generation of immune responses. The 2B4 (CD244), a member of the CD2 subset of the Ig superfamily, is the high affinity ligand for CD48. It is expressed on NK cells, T cells, monocytes, and basophils. Recent data indicate that 2B4/CD48 interactions regulate NK and T lymphocyte functions. In human NK cells, 2B4/ CD48 interaction induces activation signals, whereas in murine NK cells it sends inhibitory signals. To determine the structural basis for 2B4/CD48 interaction, selected amino acid residues in the V domain of the human 2B4 (h2B4) were mutated to alanine by site-directed mutagenesis. Following transient expression of these mutants in B16F10 melanoma cells, their interaction with soluble CD48-Fc fusion protein was assessed by flow cytometry. We identified amino acid residues in the extracellular domain of h2B4 that are involved in interacting with CD48. Binding of CD48-Fc fusion protein to RNK-16 cells stably transfected with wild-type and a double-mutant Lys68Ala-Glu70Ala h2B4 further demonstrated that Lys68 and Glu70 in the V domain of h2B4 are essential for 2B4/CD48 interaction. Functional analysis indicated that Lys68 and Glu70 in the extracellular domain of h2B4 play a key role in the activation of human NK cells through 2B4/CD48 interaction.
    [Show full text]
  • Role of CD244 and SLAM-Associated B Cell Induction of IL-13 Expression
    B Cell Induction of IL-13 Expression in NK Cells: Role of CD244 and SLAM-Associated Protein This information is current as Ning Gao, Pamela Schwartzberg, Julie A. Wilder, Bruce R. of September 26, 2021. Blazar and Dorothy Yuan J Immunol 2006; 176:2758-2764; ; doi: 10.4049/jimmunol.176.5.2758 http://www.jimmunol.org/content/176/5/2758 Downloaded from References This article cites 64 articles, 44 of which you can access for free at: http://www.jimmunol.org/content/176/5/2758.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology B Cell Induction of IL-13 Expression in NK Cells: Role of CD244 and SLAM-Associated Protein Ning Gao,* Pamela Schwartzberg,† Julie A. Wilder,‡ Bruce R. Blazar,§ and Dorothy Yuan1* NK cells are an important component of the innate immune system that can also interact with B cells in a mutually productive manner.
    [Show full text]